WDSC US 2024 : A pharmacovigilance Event | HCLTech
WDSC US
Overview

Advancing patient empowerment, enhancing safety measures

Healthcare innovation is important, but patient safety is the primary focus.

We are at the forefront of revolutionizing pharmacovigilance (PV) by leveraging cutting-edge AI technologies and extensive industry knowledge. Our strategy ensures a thorough and precise evaluation of drug safety profiles, improving safety protocols and significantly enhancing patient well-being.

We are thrilled to present our advancements at the World Drug Safety Congress US 2024. Our Global Pharmacovigilance and Epidemiology (GPV&E) team will demonstrate our ability to capture, analyze and visualize a comprehensive 360° view of healthcare product safety.

Visit booth #533 to learn how HCLTech offers a complete range of services, including R&D, preclinical trials, clinical procedures, regulatory affairs, pharmacovigilance and medical information management.

Overview

Elevating pharmacovigilance with next-generation solutions

Our state-of-the-art, are crafted to revolutionize and enhance workflow. We simplify case intake, automate the creation of aggregate reports and Risk Management Plans (RMPs), swiftly identify adverse events from digital sources and uphold the highest quality standards. By leveraging advanced AI technology, we boost the efficiency and effectiveness of pharmacovigilance processes, ensuring exceptional results.

GenAI-assisted case intake

Our solution revolutionizes case intake by quickly identifying and classifying adverse events and product inquiries from multiple sources in real time, enhancing both speed and precision

Learn more

Digital risk mitigation

Our AI-driven platform identifies and classifies adverse events, product issues and medical inquiries from digital sources, utilizing MedDRA and WHO drug dictionaries for accurate categorization. This enhances the efficiency of both reporting and analytical processes

Learn more

GenAI-assisted aggregate and RMP authoring

Our state-of-the-art genAI platform streamlines the creation of aggregate reports and Risk Management Plans (RMPs) through automated content generation. This ensures compliance with industry standards and guidelines, significantly reducing the need for manual effort.

Smart QC (quality control)

Our solution improves data integrity and compliance by embedding automated validations throughout the case processing workflow. This reduces errors and significantly enhances the quality of individual case safety reports (ICSRs).

Learn more

Analytical dashboard

Our data analytics dashboard allows users to turn data into actionable insights. With real-time interactive reports and customizable settings, it facilitates exploration, analysis, collaboration and scaling throughout the organization. Additionally, the dashboard features built-in governance and security protocols.

Speaker session

Supercharging digital evolution with GenAI in Biopharma

HCLTech is equipping biopharma clients with Generative AI to achieve exceptional business results. By strategically investing in specialized accelerators and tools designed for the biopharma sector, we facilitate our clients' responsible and impactful adoption of Generative AI.

Explore HCLTech’s GenAI-ready solutions for the biopharma industry. Our session will showcase how our technology enhances decision-making with AI-driven data analysis, streamlines operations, and implements cost-effective strategies without compromising quality or compliance. We also ensure adherence to regulatory standards, maintaining trust and avoiding penalties.

Key discussion themes:

  • GenAI-assisted solutions: Ready for immediate deployment to enhance decision-making and innovation.
  • Seamless integration: Ensuring minimal disruption and maximum efficiency in biopharma workflows.
  • Strategic cost management: Balancing innovation with budget constraints.
  • Regulatory compliance: Boosting productivity through automation and AI while maintaining compliance.
Tim Allen
Tim Allen

Global R&D Strategy Lead, Life Sciences
HCLTech

Our Team

Tim Allen
Tim Allen

Global R&D Strategy Lead
HCLTech

Kiran Singh J
Kiran Singh J

Associate General Manager, Pharmacovigilance and MedInfo
HCLTech

Warren Ryanes
Warren Ryanes

Global Director, Service Delivery
HCLTech

Steve Chole
Steve Chole

Senior Area Sales Director
HCLTech

Success Stories

Our Resources

Awards and Recognitions

Leader in Everest Group's Connected Product Engineering Services PEAK Matrix® Assessment 2024

HCLTech positioned as a Leader In Everest Group’s Healthcare Provider Digital Services PEAK Matrix® Assessment 2023

HCLTech rated as a Leader in ISG Provider Lens™ - Provider Digital Transformation Services, U.S. 2023

HCLTech positioned as a Leader in Unstructured Document Processing Products PEAK Matrix® Assessment 2023

HCLTech positioned as a Leader in Everest Group’s Connected Medical Device Services PEAK Matrix® Assessment 2022

 

Latest AI News

Press Release
October 7, 2024

HCLTech to lead the charge in AI conversations at World Summit AI 2024

Learn more

Press Release
October 3, 2024

HCLTech announces AI-based solutions powered by Intel Core Ultra processors

Learn more

Press Release
September 18, 2024

HCLTech AI Force™ integrates with Anthropic Claude 3 in Amazon Bedrock

Learn more

Press Release
September 17, 2024

HCLTech launches suite of Salesforce-based solutions to advance GenAI capabilities across industries

Learn more

Press Release
September 10, 2024

HCLTech to showcase advance engineering and AI solutions at SEMICON India

Learn more

Press Release
August 26, 2024

Xerox and HCLTech Extend Agreement to Drive Innovation with AI and Digital Engineering

Learn more